Navigation Links
Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
Date:9/12/2007

The Mount Sinai Medical Centers Head and Neck Cancer Center is teaming up with ENT and Allergy Associates, LLP to help fight cancer. The clinical alliance between Mount Sinai and ENT and Allergy Associates, the largest ear, nose and throat, allergy and audiology practice in the tri-state area, together will provide patients with a full spectrum of high quality care, cancer screening and advanced surgical options for patients diagnosed with cancer and other serious ENT conditions.

Mount Sinais new collaboration with ENT and Allergy Associates marks an exciting venture in cancer care outside the city limits, said Dr. Eric Genden, Professor and Chairman of the Department of Otolaryngology and Director of the Head and Neck Cancer Center at Mount Sinai. My extraordinary team of head and neck surgeons, neurosurgeons, oncologists, and radiologists at Mount Sinai look forward to offering patients from all over the tri-state area the widest choice of treatments including the latest minimally invasive surgical techniques.

Mount Sinai and ENT partnership will establish a series of thyroid and head and neck cancer screening centers throughout New York and New Jersey at ENT and Allergy Associates office locations. ENT physicians and Mount Sinai surgeons will work together to promote early detection, proper cancer screening guidelines and provide the latest oncology updates to all ENT physicians. Mount Sinai will offer continuous access for thyroid and head and neck cancer surgeries for all ENT and Allergy, LLP patients.

Mount Sinais head and neck cancer team has gained national recognition for its expertise and innovation in the management of head and neck cancer said Dr. Wayne Eisman, president of ENT and Allergy Associates, LLP. ENT is proud to call Mount Sinai our partner. This exciting association will provide seamless access for our patients to world class physicians offering comprehensive care for the most complicated ENT and Allergy diseases.

This year more than 55,000 Americans will develop cancer of the head and neck most of which is preventable. With this new partnership between Mount Sinai and ENT and Allergy Associates, - our goal will continue to be to promote early detection, screening and intervention to save more lives, said Dr. Eric Genden of Mount Sinai.


'/>"/>

Contact: Mount Sinai Newsroom
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related medicine news :

1. Drinking adequate amounts of water
2. Mountain biking connected to infertility
3. Reduced fertility in men who mountain bike
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
6. Epidemic Fear In Mumbai Mounting Post-Floods
7. Non-Communicable Diseases Mounting Up At An Alarming Rate in India
8. Illegal Drug Use In England Mounting Up At An Alarming Rate
9. Indonesia Has Ninth Bird-Flu Death as Risk Mounts
10. Surgeons being paid triple the amount to cut waiting lists
11. Mountain Biking Results In Serious Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: